Treatment of Viral Encephalitis in Subacute Sclerosing Panencephalitis
Subacute sclerosing panencephalitis (SSPE) is a distinct clinical presentation within the spectrum of viral encephalitis. The management of viral encephalitis in this setting requires a specific therapeutic approach that differs from standard antiviral care.
Therapeutic Approach
Current evidence supports a route of antiviral delivery that targets the central nervous system directly — bypassing conventional systemic administration. Clinical data suggest this approach can be associated with meaningful improvement in affected patients.
Partial overview only — the complete regimen, evidence grading, and clinical guidance are in the full protocol below.
References
DOI: 10.1086/589747
- Measles virus: ribavirin can be considered (C-III); intrathecal ribavirin can be considered in patients with subacute sclerosing panencephalitis (C-III).
- In 5 patients with subacute sclerosing panencephalitis, use of intraventricular ribavirin was associated with clinical improvement in 4 patients, suggesting that this mode of therapy should be further studied for its efficacy in this condition.
View source ↗